Trials / Unknown
UnknownNCT05069194
Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
Study on the Etiology, Risk Factors and Pathogenesis ofCOPD Based on Clinical Bioinformatics
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,000 (estimated)
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The risk factors and causes of chronic obstructive pulmonary disease(COPD)are not clear, so the prevalence of COPD is high and the prevention effect is not good. Because the pathogenesis of COPD is not completely elucidated, the diagnosis and classification of COPD are inaccurate which resulting in poor efficacy of treatment. Therefore, it is of great scientific and clinical significance to find out the risk factors and causes of COPD, to clarify its pathogenesis, to put forward the prevention and early intervention measures of COPD, to warn the occurrence of COPD, to predict the deterioration of the disease, to reduce the occurrence of COPD and to slow down the progress of COPD. The project establishes a cohort of COPD people,high-risk group and the healthy group. The project studys the risk factors, etiology and pathogenesis of COPD. The project studys the interaction between genetic factors and environmental factors on COPD and its effect on pathogenesis, progression and outcome of COPD.
Detailed description
The project establishes the data base and specimen bank for COPD.Then clinical bioinformatics technology is uesd to analyze the clinical information and epidemiological information. In the same time, Omics methods are used to study COPD-related genes and biomarkers . Finally, a multi-factor risk factor model for the occurrence and development of COPD is established by combining clinical information, epidemiological information and biomics results.
Conditions
Timeline
- Start date
- 2017-12-10
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-10-06
- Last updated
- 2021-10-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05069194. Inclusion in this directory is not an endorsement.